Literature DB >> 18825134

Dietary antioxidants in inflammatory arthritis: do they have any role in etiology or therapy?

Dorothy J Pattison1, Paul G Winyard.   

Abstract

Rheumatoid arthritis is an autoimmune-mediated inflammatory disease of unknown etiology, and is characterized by joint pain and soft-tissue swelling. The role of dietary antioxidants in the prevention and amelioration of symptoms in inflammatory joint disease has been of interest for many years. Epidemiological studies provide evidence of a link between dietary antioxidant intake and the likelihood of developing inflammatory arthritis. Interventional studies of antioxidant supplementation in established disease have been inconclusive overall; however, the quality of such studies has often been poor. The pathways by which antioxidant compounds might act are now better understood. In this Review, we explore not only some of the accepted mechanisms of antioxidant function but also outline some concepts that could aid further investigation of the potential therapeutic role of dietary antioxidants in inflammatory arthritis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18825134     DOI: 10.1038/ncprheum0920

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN: 1745-8382


  15 in total

1.  Ameliorative effect of p-coumaric acid, a common dietary phenol, on adjuvant-induced arthritis in rats.

Authors:  Samuel Joshua Pragasam; Vachana Murunikkara; Evan Prince Sabina; MahaboobKhan Rasool
Journal:  Rheumatol Int       Date:  2012-03-25       Impact factor: 2.631

2.  A Study on Association Between Protein Carbonyl and Anti-cyclic Citrullinated Peptide Antibody in Rheumatoid Arthritis: Introducing a New Supplementary Biomarker.

Authors:  Sahar Khorasani; Nadia Boroumand; Abdolmomen Ghaeni Pasavei; Maryam Sahebari; Seyed Isaac Hashemy
Journal:  Indian J Clin Biochem       Date:  2019-03-05

3.  The glutathione S-transferase M1 and P1 polymorphisms and rheumatoid arthritis: a meta-analysis.

Authors:  Gwan Gyu Song; Sang-Cheol Bae; Young Ho Lee
Journal:  Mol Biol Rep       Date:  2012-10-06       Impact factor: 2.316

4.  Selenium Nanoparticles (SeNPs) Immunomodulation Is More Than Redox Improvement: Serum Proteomics and Transcriptomic Analyses.

Authors:  Ivan Fan Xia; Hang-Kin Kong; Margaret M H Wu; Yishan Lu; Ka-Hing Wong; Kevin W H Kwok
Journal:  Antioxidants (Basel)       Date:  2022-05-13

Review 5.  [Diet in rheumatic disease].

Authors:  O Adam; S Fasse; O Ditrich
Journal:  Z Rheumatol       Date:  2009-09       Impact factor: 1.372

6.  Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional study.

Authors:  Ted R Mikuls; Karen A Gould; Kimberly K Bynoté; Fang Yu; Tricia D Levan; Geoffrey M Thiele; Kaleb D Michaud; James R O'Dell; Andreas M Reimold; Roderick Hooker; Liron Caplan; Dannette S Johnson; Gail Kerr; J Steuart Richards; Grant W Cannon; Lindsey A Criswell; Janelle A Noble; S Louis Bridges; Laura Hughes; Peter K Gregersen
Journal:  Arthritis Res Ther       Date:  2010-11-18       Impact factor: 5.156

Review 7.  Redox-Mediated Carbamylation As a Hapten Model Applied to the Origin of Antibodies to Modified Proteins in Rheumatoid Arthritis.

Authors:  Maria Isabel Trejo-Zambrano; Eduardo Gómez-Bañuelos; Felipe Andrade
Journal:  Antioxid Redox Signal       Date:  2021-06-04       Impact factor: 7.468

8.  L-cystathionine inhibits oxidized low density lipoprotein-induced THP-1-derived macrophage inflammatory cytokine monocyte chemoattractant protein-1 generation via the NF-κB pathway.

Authors:  Mingzhu Zhu; Junbao Du; Angie Dong Liu; Lukas Holmberg; Selena Y Chen; Dingfang Bu; Chaoshu Tang; Hongfang Jin
Journal:  Sci Rep       Date:  2015-05-28       Impact factor: 4.379

Review 9.  Nanomedicine in the ROS-mediated pathophysiology: Applications and clinical advances.

Authors:  Kevin M Nash; Salahuddin Ahmed
Journal:  Nanomedicine       Date:  2015-08-06       Impact factor: 5.307

10.  Lymphocytes from rheumatoid arthritis patients have elevated levels of intracellular peroxiredoxin 2, and a greater frequency of cells with exofacial peroxiredoxin 2, compared with healthy human lymphocytes.

Authors:  Katalin É Szabó-Taylor; Paul Eggleton; Carly A L Turner; M Letizia Lo Faro; Joanna M Tarr; Sára Tóth; Matt Whiteman; Richard C Haigh; Jennifer A Littlechild; Paul G Winyard
Journal:  Int J Biochem Cell Biol       Date:  2012-04-28       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.